Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Interleukin Genetics applies for inflammatory gene patent

Sep. 15, 1999

Chiron seeks U.K. approval for meningitis vaccine

Sep. 14, 1999

Merck & Co. launches preservative-free HBV vaccine

Sep. 13, 1999

Selective glucocorticoid receptor modulators emerge from Abbott-Ligand collaboration

Sep. 13, 1999

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Sep. 8, 1999

Novel B-cell-selective immunomodulators useful in transplantation, autoimmune diseases

Sep. 6, 1999

Orally active prodigiosine compounds claimed for immunosuppression, Rx of T-cell leukemia-lymphoma

Sep. 3, 1999

PowderJect begins clinical study of DNA malaria vaccine

Sep. 3, 1999

Stanford team develops effective method for topical genetic immunization

Sep. 2, 1999

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Sep. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...